Karen E. Ross
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Karen E. Ross has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
Fatos Kirkali
41 shared publicationsJulie Cowart
41 shared publications- Khoa Dang P. Nguyen
Thoracic and GI Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland
41 shared publications - Meghana Keswani
Thoracic and GI Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland
41 shared publications Meriam Bahta
41 shared publicationsShaojian Gao
41 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by Springer Nature in BMC Bioinformatics
GenPTM: a generalizable framework for protein post-translational modification information extraction from the scientific literature
Background: Protein post-translational modification (PTM) plays a pivotal role in cellular activities and biological processes. Although several databases curate PTM information, most cover only a limited number of PTMs. Although the scientific literature continues to accumulate a vast amount of PTM-related knowledge, these databases are not updated regularly. This growing information gap highlights the need for automated information extraction (IE) systems that can identify modified proteins and their specific amino acid sites directly from the literature. While numerous PTMs have been reported in scientific articles, most existing tools are designed only for a few specific PTMs, and developing separate systems for every PTM is not feasible. Methods: To address this challenge, we developed GenPTM, a generalized and adaptable IE tool that identifies modified proteins and sites from PubMed abstracts using a unified text representation strategy. GenPTM replaces PTM-specific modification and chemical group mentions with generic placeholders, allowing the model to focus on shared textual patterns that express modification events. A BiomedBERT-based classifier is fine-tuned to determine whether a candidate protein or site is truly modified, and a post-processing module assembles the final protein, site, or protein-site pair predictions. Results: Trained on five major PTM types (e.g., Ubiquitination, Phosphorylation) and evaluated on eight additional PTMs, including PTMs that are not frequently mentioned (e.g., Citrullination, AMPylation), GenPTM achieves F1-scores ranging from 92% to 96% across all PTMs for three different evaluation categories. Conclusions: These results exhibit strong generalization capability of GenPTM by providing a viable solution for PTM-agnostic IE and automated PTM knowledge discovery in proteomics.
- 24 September 2026
- Published by Springer Nature in BMC Bioinformatics
Open AccessGenPTM: a generalizable framework for protein post-translational modification information extraction from the scientific literature
Background: Protein post-translational modification (PTM) plays a pivotal role in cellular activities and biological processes. Although several databases curate PTM information, most cover only a limited number of PTMs. Although the scientific literature continues to accumulate a vast amount of PTM-related knowledge, these databases are not updated regularly. This growing information gap highlights the need for automated information extraction (IE) systems that can identify modified proteins and their specific amino acid sites directly from the literature. While numerous PTMs have been reported in scientific articles, most existing tools are designed only for a few specific PTMs, and developing separate systems for every PTM is not feasible. Methods: To address this challenge, we developed GenPTM, a generalized and adaptable IE tool that identifies modified proteins and sites from PubMed abstracts using a unified text representation strategy. GenPTM replaces PTM-specific modification and chemical group mentions with generic placeholders, allowing the model to focus on shared textual patterns that express modification events. A BiomedBERT-based classifier is fine-tuned to determine whether a candidate protein or site is truly modified, and a post-processing module assembles the final protein, site, or protein-site pair predictions. Results: Trained on five major PTM types (e.g., Ubiquitination, Phosphorylation) and evaluated on eight additional PTMs, including PTMs that are not frequently mentioned (e.g., Citrullination, AMPylation), GenPTM achieves F1-scores ranging from 92% to 96% across all PTMs for three different evaluation categories. Conclusions: These results exhibit strong generalization capability of GenPTM by providing a viable solution for PTM-agnostic IE and automated PTM knowledge discovery in proteomics.
- Open Access
- 28 April 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (4) , e0347773
A network-centric approach reveals novel pathways impacted by Prader-Willi Syndrome
Prader-Willi Syndrome (PWS), a rare multi-system disorder characterized by insatiable appetite, growth abnormalities, and cognitive delay, results from genetic defects in a paternally expressed region of chromosome 15, q11.2-q13. This region contains several protein-coding genes and several genes encoding small nucleolar RNA (snoRNAs), including the SNORD116 gene cluster, but their exact role in PWS remains unclear. Since snoRNAs have wide-ranging effects on protein expression and proteins interact in a complex network, the genetic aberrations causing PWS are likely to cause far-reaching indirect effects on protein expression and activity. Here, we mapped PWS gene expression data onto a human protein-protein interaction (PPI) network and used graph learning techniques to 1) identify the most impacted proteins and 2) suggest novel disease mechanisms. We adapted GeneEMBED, a network-based method originally developed to model genetic variants associated with Alzheimer’s Disease. Specifically, we integrated PWS or control expression data with the PPI network, calculated node embeddings, and identified proteins with large differences between PWS and control embeddings. These candidate proteins were subjected to functional enrichment analysis to discover altered biological processes in PWS. Candidate proteins were highly enriched for glycosylated proteins. Analysis of candidate glycosylation enzymes suggested abnormalities in mucin-type O-glycosylation, fucosylation, and glycosaminoglycan synthesis. Defects in these glycosylation pathways have been linked to several PWS phenotypes, including obesity, cognitive delay, and production of secondary sex hormones. Homeobox proteins, master regulators of transcription during development, were also overrepresented among the candidate proteins. In particular, we identified homeobox proteins that drive development of GABAergic and dopaminergic neurons. These neuronal pathways regulate appetite and other behaviors that are abnormal in individuals with PWS. Our results were highly reproducible across PWS model systems. This work offers new avenues for further research in PWS and provides a promising approach that can be applied to other complex diseases.
- 28 April 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (4) , e0347773
Open AccessA network-centric approach reveals novel pathways impacted by Prader-Willi Syndrome
Prader-Willi Syndrome (PWS), a rare multi-system disorder characterized by insatiable appetite, growth abnormalities, and cognitive delay, results from genetic defects in a paternally expressed region of chromosome 15, q11.2-q13. This region contains several protein-coding genes and several genes encoding small nucleolar RNA (snoRNAs), including the SNORD116 gene cluster, but their exact role in PWS remains unclear. Since snoRNAs have wide-ranging effects on protein expression and proteins interact in a complex network, the genetic aberrations causing PWS are likely to cause far-reaching indirect effects on protein expression and activity. Here, we mapped PWS gene expression data onto a human protein-protein interaction (PPI) network and used graph learning techniques to 1) identify the most impacted proteins and 2) suggest novel disease mechanisms. We adapted GeneEMBED, a network-based method originally developed to model genetic variants associated with Alzheimer’s Disease. Specifically, we integrated PWS or control expression data with the PPI network, calculated node embeddings, and identified proteins with large differences between PWS and control embeddings. These candidate proteins were subjected to functional enrichment analysis to discover altered biological processes in PWS. Candidate proteins were highly enriched for glycosylated proteins. Analysis of candidate glycosylation enzymes suggested abnormalities in mucin-type O-glycosylation, fucosylation, and glycosaminoglycan synthesis. Defects in these glycosylation pathways have been linked to several PWS phenotypes, including obesity, cognitive delay, and production of secondary sex hormones. Homeobox proteins, master regulators of transcription during development, were also overrepresented among the candidate proteins. In particular, we identified homeobox proteins that drive development of GABAergic and dopaminergic neurons. These neuronal pathways regulate appetite and other behaviors that are abnormal in individuals with PWS. Our results were highly reproducible across PWS model systems. This work offers new avenues for further research in PWS and provides a promising approach that can be applied to other complex diseases.
- Open Access
- 26 December 2024
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 5 (1) , vbaf289
KSMoFinder—knowledge graph embedding of proteins and motifs for predicting kinases of human phosphosites
Motivation: Protein kinases regulate cellular signaling pathways through a cascade of phosphorylation activity, selectively targeting specific residues on substrate proteins (phosphosites). Determining the characteristics of kinases that phosphorylate specific substrates have been extensively studied. Most tools utilize amino acid sequence motifs around phosphosites but don’t consider substrate protein’s biological characteristics. Results: We present KSMoFinder, a kinase-substrate-motif prediction model that learns factors beyond motif similarities by integrating proteins’ biological contexts. We learn the semantics in a knowledge graph containing proteins’ contextual relationships, kinase-specific motifs and motif composition, and represent the proteins and motifs as vectors. Using the representations as features, we train a supervised deep-learning classifier to identify kinase–phosphosite relationships. We use ground truth kinase-substrate-motif dataset from iPTMnet and PhosphositePlus and evaluate KSMoFinder’s prediction performance. Pairwise comparative assessments with prior kinase-substrate prediction tools demonstrate KSMoFinder’s superior performance. KSMoFinder trained using our knowledge graph embeddings surpasses the prediction performances using embeddings of popular protein language models such as ProtT5, ESM2, and ESM3 with a ROC-AUC of 0.851 and PR-AUC of 0.839 on a testing dataset with equal number of positives and negatives. Unlike most existing tools, KSMoFinder can be utilized to predict at the motif and at the substrate protein level. Availability and implementation: Source code is available at https://github.com/manju-anandakrishnan/KSMoFinder.
- 26 December 2024
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 5 (1) , vbaf289
Open AccessKSMoFinder—knowledge graph embedding of proteins and motifs for predicting kinases of human phosphosites
Motivation: Protein kinases regulate cellular signaling pathways through a cascade of phosphorylation activity, selectively targeting specific residues on substrate proteins (phosphosites). Determining the characteristics of kinases that phosphorylate specific substrates have been extensively studied. Most tools utilize amino acid sequence motifs around phosphosites but don’t consider substrate protein’s biological characteristics. Results: We present KSMoFinder, a kinase-substrate-motif prediction model that learns factors beyond motif similarities by integrating proteins’ biological contexts. We learn the semantics in a knowledge graph containing proteins’ contextual relationships, kinase-specific motifs and motif composition, and represent the proteins and motifs as vectors. Using the representations as features, we train a supervised deep-learning classifier to identify kinase–phosphosite relationships. We use ground truth kinase-substrate-motif dataset from iPTMnet and PhosphositePlus and evaluate KSMoFinder’s prediction performance. Pairwise comparative assessments with prior kinase-substrate prediction tools demonstrate KSMoFinder’s superior performance. KSMoFinder trained using our knowledge graph embeddings surpasses the prediction performances using embeddings of popular protein language models such as ProtT5, ESM2, and ESM3 with a ROC-AUC of 0.851 and PR-AUC of 0.839 on a testing dataset with equal number of positives and negatives. Unlike most existing tools, KSMoFinder can be utilized to predict at the motif and at the substrate protein level. Availability and implementation: Source code is available at https://github.com/manju-anandakrishnan/KSMoFinder.
- Open Access
- 1 January 2024
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 4 (1) , vbae057
Perspectives on tracking data reuse across biodata resources
Motivation: Data reuse is a common and vital practice in molecular biology and enables the knowledge gathered over recent decades to drive discovery and innovation in the life sciences. Much of this knowledge has been collated into molecular biology databases, such as UniProtKB, and these resources derive enormous value from sharing data among themselves. However, quantifying and documenting this kind of data reuse remains a challenge. Results: The article reports on a one-day virtual workshop hosted by the UniProt Consortium in March 2023, attended by representatives from biodata resources, experts in data management, and NIH program managers. Workshop discussions focused on strategies for tracking data reuse, best practices for reusing data, and the challenges associated with data reuse and tracking. Surveys and discussions showed that data reuse is widespread, but critical information for reproducibility is sometimes lacking. Challenges include costs of tracking data reuse, tensions between tracking data and open sharing, restrictive licenses, and difficulties in tracking commercial data use. Recommendations that emerged from the discussion include: development of standardized formats for documenting data reuse, education about the obstacles posed by restrictive licenses, and continued recognition by funding agencies that data management is a critical activity that requires dedicated resources. Availability and implementation: Summaries of survey results are available at: https://docs.google.com/forms/d/1j-VU2ifEKb9C-sW6l3ATB79dgHdRk5v_lESv2hawnso/viewanalytics (survey of data providers) and https://docs.google.com/forms/d/18WbJFutUd7qiZoEzbOytFYXSfWFT61hVce0vjvIwIjk/viewanalytics (survey of users).
- 1 January 2024
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 4 (1) , vbae057
Open AccessPerspectives on tracking data reuse across biodata resources
Motivation: Data reuse is a common and vital practice in molecular biology and enables the knowledge gathered over recent decades to drive discovery and innovation in the life sciences. Much of this knowledge has been collated into molecular biology databases, such as UniProtKB, and these resources derive enormous value from sharing data among themselves. However, quantifying and documenting this kind of data reuse remains a challenge. Results: The article reports on a one-day virtual workshop hosted by the UniProt Consortium in March 2023, attended by representatives from biodata resources, experts in data management, and NIH program managers. Workshop discussions focused on strategies for tracking data reuse, best practices for reusing data, and the challenges associated with data reuse and tracking. Surveys and discussions showed that data reuse is widespread, but critical information for reproducibility is sometimes lacking. Challenges include costs of tracking data reuse, tensions between tracking data and open sharing, restrictive licenses, and difficulties in tracking commercial data use. Recommendations that emerged from the discussion include: development of standardized formats for documenting data reuse, education about the obstacles posed by restrictive licenses, and continued recognition by funding agencies that data management is a critical activity that requires dedicated resources. Availability and implementation: Summaries of survey results are available at: https://docs.google.com/forms/d/1j-VU2ifEKb9C-sW6l3ATB79dgHdRk5v_lESv2hawnso/viewanalytics (survey of data providers) and https://docs.google.com/forms/d/18WbJFutUd7qiZoEzbOytFYXSfWFT61hVce0vjvIwIjk/viewanalytics (survey of users).
- Open Access
KSFinder—a knowledge graph model for link prediction of novel phosphorylated substrates of kinases
Background Aberrant protein kinase regulation leading to abnormal substrate phosphorylation is associated with several human diseases. Despite the promise of therapies targeting kinases, many human kinases remain understudied. Most existing computational tools predicting phosphorylation cover less than 50% of known human kinases. They utilize local feature selection based on protein sequences, motifs, domains, structures, and/or functions, and do not consider the heterogeneous relationships of the proteins. In this work, we present KSFinder, a tool that predicts kinase-substrate links by capturing the inherent association of proteins in a network comprising 85% of the known human kinases. We also postulate the potential role of two understudied kinases based on their substrate predictions from KSFinder. Methods KSFinder learns the semantic relationships in a phosphoproteome knowledge graph using a knowledge graph embedding algorithm and represents the nodes in low-dimensional vectors. A multilayer perceptron (MLP) classifier is trained to discern kinase-substrate links using the embedded vectors. KSFinder uses a strategic negative generation approach that eliminates biases in entity representation and combines data from experimentally validated non-interacting protein pairs, proteins from different subcellular locations, and random sampling. We assess KSFinder’s generalization capability on four different datasets and compare its performance with other state-of-the-art prediction models. We employ KSFinder to predict substrates of 68 “dark” kinases considered understudied by the Illuminating the Druggable Genome program and use our text-mining tool, RLIMS-P along with manual curation, to search for literature evidence for the predictions. In a case study, we performed functional enrichment analysis for two dark kinases - HIPK3 and CAMKK1 using their predicted substrates. Results KSFinder shows improved performance over other kinase-substrate prediction models and generalized prediction ability on different datasets. We identified literature evidence for 17 novel predictions involving an understudied kinase. All of these 17 predictions had a probability score ≥0.7 (nine at >0.9, six at 0.8–0.9, and two at 0.7–0.8). The evaluation of 93,593 negative predictions (probability ≤0.3) identified four false negatives. The top enriched biological processes of HIPK3 substrates relate to the regulation of extracellular matrix and epigenetic gene expression, while CAMKK1 substrates include lipid storage regulation and glucose homeostasis. Conclusions KSFinder outperforms the current kinase-substrate prediction tools with higher kinase coverage. The strategically developed negatives provide a superior generalization ability for KSFinder. We predicted substrates of 432 kinases, 68 of which are understudied, and hypothesized the potential functions of two dark kinases using their predicted substrates.
Open AccessKSFinder—a knowledge graph model for link prediction of novel phosphorylated substrates of kinases
Background Aberrant protein kinase regulation leading to abnormal substrate phosphorylation is associated with several human diseases. Despite the promise of therapies targeting kinases, many human kinases remain understudied. Most existing computational tools predicting phosphorylation cover less than 50% of known human kinases. They utilize local feature selection based on protein sequences, motifs, domains, structures, and/or functions, and do not consider the heterogeneous relationships of the proteins. In this work, we present KSFinder, a tool that predicts kinase-substrate links by capturing the inherent association of proteins in a network comprising 85% of the known human kinases. We also postulate the potential role of two understudied kinases based on their substrate predictions from KSFinder. Methods KSFinder learns the semantic relationships in a phosphoproteome knowledge graph using a knowledge graph embedding algorithm and represents the nodes in low-dimensional vectors. A multilayer perceptron (MLP) classifier is trained to discern kinase-substrate links using the embedded vectors. KSFinder uses a strategic negative generation approach that eliminates biases in entity representation and combines data from experimentally validated non-interacting protein pairs, proteins from different subcellular locations, and random sampling. We assess KSFinder’s generalization capability on four different datasets and compare its performance with other state-of-the-art prediction models. We employ KSFinder to predict substrates of 68 “dark” kinases considered understudied by the Illuminating the Druggable Genome program and use our text-mining tool, RLIMS-P along with manual curation, to search for literature evidence for the predictions. In a case study, we performed functional enrichment analysis for two dark kinases - HIPK3 and CAMKK1 using their predicted substrates. Results KSFinder shows improved performance over other kinase-substrate prediction models and generalized prediction ability on different datasets. We identified literature evidence for 17 novel predictions involving an understudied kinase. All of these 17 predictions had a probability score ≥0.7 (nine at >0.9, six at 0.8–0.9, and two at 0.7–0.8). The evaluation of 93,593 negative predictions (probability ≤0.3) identified four false negatives. The top enriched biological processes of HIPK3 substrates relate to the regulation of extracellular matrix and epigenetic gene expression, while CAMKK1 substrates include lipid storage regulation and glucose homeostasis. Conclusions KSFinder outperforms the current kinase-substrate prediction tools with higher kinase coverage. The strategically developed negatives provide a superior generalization ability for KSFinder. We predicted substrates of 432 kinases, 68 of which are understudied, and hypothesized the potential functions of two dark kinases using their predicted substrates.
- Open Access
- 13 August 2023
- Published by Wiley in Molecular Microbiology
- Vol. 120 (5) , 658-669
The insertion sequence excision enhancer: A PrimPol‐based primer invasion system for immobilizing transposon‐transmitted antibiotic resistance genes
Evolutionary studies often identify genes that have been exchanged between different organisms and the phrase Lateral or Horizontal Gene Transfer is often used in this context. However, they rarely provide any mechanistic information concerning how these gene transfers might have occurred. With the astonishing increase in the number of sequences in public databases over the past two or three decades, identical antibiotic resistance genes have been identified in many different sequence contexts. One explanation for this would be that genes are initially transmitted by transposons which have subsequently decayed and can no longer be detected. Here, we provide an overview of a protein, IEE (Insertion Sequence Excision Enhancer) observed to facilitate high‐frequency excision of IS629 from clinically important Escherichia coli O157:H7 and subsequently shown to affect a large class of bacterial insertion sequences which all transpose using the copy‐out‐paste‐in transposition mechanism. Excision depends on both IEE and transposase indicating association with the transposition process itself. We review genetic and biochemical data and propose that IEE immobilizes genes carried by compound transposons by removing the flanking insertion sequence (IS) copies. The biochemical activities of IEE as a primase with the capacity to recognize DNA microhomologies and the observation that its effect appears restricted to IS families which use copy‐out‐paste‐in transposition, suggests IS deletion occurs by abortive transposition involving strand switching (primer invasion) during the copy‐out step. This reinforces the proposal made for understanding the widespread phenomenon loss of ISApl1 flanking mcr‐1 in the compound transposon Tn6330 which we illustrate with a detailed model. This model also provides a convincing way to explain the high levels of IEE‐induced precise IS excision.
- 13 August 2023
- Published by Wiley in Molecular Microbiology
- Vol. 120 (5) , 658-669
Open AccessThe insertion sequence excision enhancer: A PrimPol‐based primer invasion system for immobilizing transposon‐transmitted antibiotic resistance genes
Evolutionary studies often identify genes that have been exchanged between different organisms and the phrase Lateral or Horizontal Gene Transfer is often used in this context. However, they rarely provide any mechanistic information concerning how these gene transfers might have occurred. With the astonishing increase in the number of sequences in public databases over the past two or three decades, identical antibiotic resistance genes have been identified in many different sequence contexts. One explanation for this would be that genes are initially transmitted by transposons which have subsequently decayed and can no longer be detected. Here, we provide an overview of a protein, IEE (Insertion Sequence Excision Enhancer) observed to facilitate high‐frequency excision of IS629 from clinically important Escherichia coli O157:H7 and subsequently shown to affect a large class of bacterial insertion sequences which all transpose using the copy‐out‐paste‐in transposition mechanism. Excision depends on both IEE and transposase indicating association with the transposition process itself. We review genetic and biochemical data and propose that IEE immobilizes genes carried by compound transposons by removing the flanking insertion sequence (IS) copies. The biochemical activities of IEE as a primase with the capacity to recognize DNA microhomologies and the observation that its effect appears restricted to IS families which use copy‐out‐paste‐in transposition, suggests IS deletion occurs by abortive transposition involving strand switching (primer invasion) during the copy‐out step. This reinforces the proposal made for understanding the widespread phenomenon loss of ISApl1 flanking mcr‐1 in the compound transposon Tn6330 which we illustrate with a detailed model. This model also provides a convincing way to explain the high levels of IEE‐induced precise IS excision.
- Open Access
The Insertion Sequence Excision Enhancer (IEE): a PrimPol-based system for Immobilizing Transposon-Transmitted Antibiotic Resistance Genes?
We provide an overview of a protein, IEE (Insertion Sequence Excision Enhancer), which was originally observed to facilitate high levels of excision of the IS3 family member, IS629, from clinically important Escherichia coli O157:H7. IEE was subsequently shown to affect a large class of bacterial insertion sequences which all transpose by producing a circular intermediate and presumably use the copy-out-paste-in transposition mechanism. Excision is dependent on both IEE and transposase indicating that it is associated with the transposition process itself. We propose that IEE serves to immobilize genes carried by compound transposons by removing the flanking IS copies, an activity which would explain the presence of certain of these genes without associated IS copies in plasmids and chromosomes. The biochemical activities of IEE as a primase with the capacity to recognize microhomologies, together with the observation that its effect appears to be restricted to those IS families which probably use the copy-out-paste-in transposition pathway, suggests a strand switch mechanism during the copy-out step leading to abortive transposition. This reinforces the proposal made for understanding the loss of the IS 30 family member, IS Apl1 , which flanks the mcr -1 gene in the compound transposon Tn 6330 .
Open AccessThe Insertion Sequence Excision Enhancer (IEE): a PrimPol-based system for Immobilizing Transposon-Transmitted Antibiotic Resistance Genes?
We provide an overview of a protein, IEE (Insertion Sequence Excision Enhancer), which was originally observed to facilitate high levels of excision of the IS3 family member, IS629, from clinically important Escherichia coli O157:H7. IEE was subsequently shown to affect a large class of bacterial insertion sequences which all transpose by producing a circular intermediate and presumably use the copy-out-paste-in transposition mechanism. Excision is dependent on both IEE and transposase indicating that it is associated with the transposition process itself. We propose that IEE serves to immobilize genes carried by compound transposons by removing the flanking IS copies, an activity which would explain the presence of certain of these genes without associated IS copies in plasmids and chromosomes. The biochemical activities of IEE as a primase with the capacity to recognize microhomologies, together with the observation that its effect appears to be restricted to those IS families which probably use the copy-out-paste-in transposition pathway, suggests a strand switch mechanism during the copy-out step leading to abortive transposition. This reinforces the proposal made for understanding the loss of the IS 30 family member, IS Apl1 , which flanks the mcr -1 gene in the compound transposon Tn 6330 .
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance
Lung cancer is the leading cause of cancer mortality worldwide. The treatment of patients with lung cancer harboring mutant EGFR with orally administered EGFR tyrosine kinase inhibitors (TKI) has been a paradigm shift. Osimertinib and rociletinib are third-generation irreversible EGFR TKIs targeting the EGFR T790M mutation. Osimertinib is the current standard of care for patients with EGFR mutations due to increased efficacy, lower side effects, and enhanced brain penetrance. Unfortunately, all patients develop resistance. Genomic approaches have primarily been used to interrogate resistance mechanisms. Here we characterized the proteome and phosphoproteome of a series of isogenic EGFR-mutant lung adenocarcinoma cell lines that are either sensitive or resistant to these drugs, comprising the most comprehensive proteomic dataset resource to date to investigate third generation EGFR TKI resistance in lung adenocarcinoma. Unbiased global quantitative mass spectrometry uncovered alterations in signaling pathways, revealed a proteomic signature of epithelial–mesenchymal transition, and identified kinases and phosphatases with altered expression and phosphorylation in TKI-resistant cells. Decreased tyrosine phosphorylation of key sites in the phosphatase SHP2 suggests its inhibition, resulting in subsequent inhibition of RAS/MAPK and activation of PI3K/AKT pathways. Anticorrelation analyses of this phosphoproteomic dataset with published drug-induced P100 phosphoproteomic datasets from the Library of Integrated Network-Based Cellular Signatures program predicted drugs with the potential to overcome EGFR TKI resistance. The PI3K/MTOR inhibitor dactolisib in combination with osimertinib overcame resistance both in vitro and in vivo. Taken together, this study reveals global proteomic alterations upon third generation EGFR TKI resistance and highlights potential novel approaches to overcome resistance.Significance:Global quantitative proteomics reveals changes in the proteome and phosphoproteome in lung cancer cells resistant to third generation EGFR TKIs, identifying the PI3K/mTOR inhibitor dactolisib as a potential approach to overcome resistance.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance
Lung cancer is the leading cause of cancer mortality worldwide. The treatment of patients with lung cancer harboring mutant EGFR with orally administered EGFR tyrosine kinase inhibitors (TKI) has been a paradigm shift. Osimertinib and rociletinib are third-generation irreversible EGFR TKIs targeting the EGFR T790M mutation. Osimertinib is the current standard of care for patients with EGFR mutations due to increased efficacy, lower side effects, and enhanced brain penetrance. Unfortunately, all patients develop resistance. Genomic approaches have primarily been used to interrogate resistance mechanisms. Here we characterized the proteome and phosphoproteome of a series of isogenic EGFR-mutant lung adenocarcinoma cell lines that are either sensitive or resistant to these drugs, comprising the most comprehensive proteomic dataset resource to date to investigate third generation EGFR TKI resistance in lung adenocarcinoma. Unbiased global quantitative mass spectrometry uncovered alterations in signaling pathways, revealed a proteomic signature of epithelial–mesenchymal transition, and identified kinases and phosphatases with altered expression and phosphorylation in TKI-resistant cells. Decreased tyrosine phosphorylation of key sites in the phosphatase SHP2 suggests its inhibition, resulting in subsequent inhibition of RAS/MAPK and activation of PI3K/AKT pathways. Anticorrelation analyses of this phosphoproteomic dataset with published drug-induced P100 phosphoproteomic datasets from the Library of Integrated Network-Based Cellular Signatures program predicted drugs with the potential to overcome EGFR TKI resistance. The PI3K/MTOR inhibitor dactolisib in combination with osimertinib overcame resistance both in vitro and in vivo. Taken together, this study reveals global proteomic alterations upon third generation EGFR TKI resistance and highlights potential novel approaches to overcome resistance.Significance:Global quantitative proteomics reveals changes in the proteome and phosphoproteome in lung cancer cells resistant to third generation EGFR TKIs, identifying the PI3K/mTOR inhibitor dactolisib as a potential approach to overcome resistance.